SK Plasma Co.,Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SK Plasma Co.,Ltd. - overview
Established
2015
Location
Seongnam, Gyeonggi, South Korea
Primary Industry
Medical Devices & Equipment
About
Based in Seongnam, South Korea, and founded in 2015, SK Plasma Co. ,Ltd. is a company specializing in blood products, was spun off from SK Chemicals. Blood products are collected by human plasma fractionation, congestion, virus inactivation, and removal through a process that refers to the production of medicines.
In 2016, a new blood product fractionation plant was completed in Andong and commercial production began in August 2018 with KGMP approval. The company produces a number of plasma-derived products such as human immunoglobulin rib-gamma S&J, human immunoglobulin hepabulin S&N, which consists of antibodies against hepatitis B virus, human serum albumin, SK antithrombin III, and tetabulin S&J.
Current Investors
TiumBio Co., Ltd., SK Discovery , STIC Investments
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Supplies, Specialty Pharmaceuticals
Website
www.skplasma.com
Verticals
HealthTech, Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.